Mater news

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

Mater researcher Professor Geoff Faulkner and his lab have published a paper that explores the development of resistance to chemotherapy in ovarian cancer. Each year ...